1 / 7

JSB Market Research: PharmaPoint: Dry Eye Syndrome

The Dry Eye Syndrome (DES) pipeline is strong, with 49 molecules in various phases of development. More notably, the late-stage pipeline has three products with novel mechanisms of action to treat the inflammation associated with the disease. That said, physicians suggest that the largest unmet need for DES treatment is diagnosis.

michaeldellk22
Télécharger la présentation

JSB Market Research: PharmaPoint: Dry Eye Syndrome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PharmaPoint: Dry Eye Syndrome - Global Drug Forecast and Market Analysis to 2022 To buy this Report Visit http://www.jsbmarketresearch.com

  2. Summary The Dry Eye Syndrome (DES) pipeline is strong, with 49 molecules in various phases of development. More notably, the late-stage pipeline has three products with novel mechanisms of action to treat the inflammation associated with the disease. That said, physicians suggest that the largest unmet need for DES treatment is diagnosis.

  3. Key Finding OfThis Report: • The global DES therapeutics market is forecast to reach $5.47 billion by 2022 due to the launch of novel pipeline drugs and an aging population. • The global push for increased physician and patient awareness will increase diagnosis and treatment. • By 2022, the DES market will be significantly more competitive, but the current dearth of treatment options leave much room for the coming pipeline therapies. To know more about this report click here – http://www.jsbmarketresearch.com/healthcare-medical/r-PharmaPoint-Dry-Eye-Syndrome-Global-Drug-Forecast-and-Market-Analysis-118885

  4. PharmaPoint: Dry Eye Syndrome - Global Drug Forecast and Market Analysis to 2022 Disease Overview Epidemiology Disease Management Opportunity and Unmet Need

  5. Related Market Research Report • Chick-fil-A, Inc.: Foodservice - Company Profile and SWOT Report • Fish and Seafood Market in Moldova: Databook to 2017 • Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018 • Global Clean Coal Technologies Market 2014-2018

  6. About JSB Market Research • Jsbmarketresearch.com is an online repository of an extensive collection of market research reports available online. This online portal contains high-quality reports with well-researched and high-quality content on a wide range of industries. These market research reports help us give a detailed insight into new opportunities in the industry, prevailing market trends, competitor analysis and future prospects. • JSB’s reports are developed by the domain experts and publishers under a closely observed surveillance of industry specialists. Therefore, the researched data is well researched, well- organized and matching up to the best standards in the industry. Also JSB’s database consists of detailed insights of the leading players in the global market, products and trends.

  7. Contact Us Support & General Inquiries Mail :support@jsbmarketresearch.com+91 - 998 729 5242 Billing Support Mail :billing@jsbmarketresearch.com+91 22 412 366 50 Websitehttp://www.jsbmarketresearch.com

More Related